IOBENGUANE SULFATE I 131 Drug Patent Profile
✉ Email this page to a colleague
When do Iobenguane Sulfate I 131 patents expire, and when can generic versions of Iobenguane Sulfate I 131 launch?
Iobenguane Sulfate I 131 is a drug marketed by Pharmalucence and is included in one NDA.
The generic ingredient in IOBENGUANE SULFATE I 131 is iobenguane sulfate i-131. Additional details are available on the iobenguane sulfate i-131 profile page.
US Patents and Regulatory Information for IOBENGUANE SULFATE I 131
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmalucence | IOBENGUANE SULFATE I 131 | iobenguane sulfate i-131 | INJECTABLE;INJECTION | 020084-001 | Mar 25, 1994 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
